Based on the functions of m6A in AML, there have been some inhibitors targeting m6A, such as the METTL3 inhibitors STM2457 and UZH1a and the FTO inhibitors FB23-2, CS1 and CS2. The gene discussed is FTO; the disease is acute myeloid leukemia.